{"id":81661,"date":"2026-06-11T00:00:24","date_gmt":"2026-06-11T00:00:24","guid":{"rendered":"https:\/\/english.saigonbiz.com\/vn\/frost-sullivan-global-pharmaceutical-industry-faces-a-high-stakes-reset-as-ai-biologics-and-supply-resilience-redefine-growth-through-2031\/"},"modified":"2026-06-11T00:00:24","modified_gmt":"2026-06-11T00:00:24","slug":"frost-sullivan-global-pharmaceutical-industry-faces-a-high-stakes-reset-as-ai-biologics-and-supply-resilience-redefine-growth-through-2031","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/frost-sullivan-global-pharmaceutical-industry-faces-a-high-stakes-reset-as-ai-biologics-and-supply-resilience-redefine-growth-through-2031\/","title":{"rendered":"Frost &amp; Sullivan: Global Pharmaceutical Industry Faces a High-Stakes Reset as AI, Biologics, and Supply Resilience Redefine Growth Through 2031"},"content":{"rendered":"<div>\n<p class=\"prntac\"><i>New Frost &amp; Sullivan analysis reveals that future winners will be those that can execute faster, industrialise innovation, and navigate mounting pricing and geopolitical pressures<\/i><\/p>\n<p><span class=\"legendSpanClass\">LONDON<\/span>, <span class=\"legendSpanClass\">June 11, 2026<\/span> \/PRNewswire\/ &#8212; Frost &amp; Sullivan&#8217;s latest analysis, <i>Growth Opportunities in Global Pharmaceutical Industry, 2026<\/i>, finds that the pharmaceutical industry is entering a period of profound transformation as affordability mandates, patent expiries, geopolitical fragmentation, and rapid technological advances reshape the foundations of value creation.<\/p>\n<p>According to the study, traditional drivers of success are being replaced by a new set of competitive imperatives centred on execution excellence, supply resilience, AI-enabled operations, and the ability to commercialise increasingly complex therapeutic modalities at scale.<\/p>\n<p>&#8220;2026 marks a decisive reset for global biopharma,&#8221; said <b>Surbhi Gupta, Industry Principal at Frost &amp; Sullivan<\/b>. &#8220;Commercial success will depend less on historical peak-sales models and more on how quickly companies can generate evidence, secure market access, integrate innovation, and reliably deliver advanced therapies in increasingly complex operating environments.&#8221;<\/p>\n<p>The analysis highlights five themes that will define the next phase of industry growth. Policy reforms, accelerating patent expiries, and intensifying pricing pressures are compressing traditional value-capture windows, forcing organisations to generate evidence earlier, strengthen lifecycle management strategies, and accelerate market access efforts. At the same time, deliverability is emerging as a critical source of competitive advantage, with manufacturing readiness, cold-chain integrity, quality assurance, and site-of-care preparedness becoming essential differentiators in an era of increasingly sophisticated therapies.<\/p>\n<p>Innovation models are also evolving as pharmaceutical companies become more selective in their investments, prioritising scalable assets, high-conviction opportunities, and their ability to rapidly integrate and operationalise external innovation. Meanwhile, supply resilience has shifted from an operational concern to a strategic imperative, as governments and regulators place greater emphasis on localisation, continuity, and security of supply amid geopolitical uncertainty. Finally, artificial intelligence is moving beyond experimentation into governed, audit-ready workflows embedded across discovery, clinical operations, quality, manufacturing, and commercial functions, creating the foundations for more efficient and data-driven operating models.<\/p>\n<p>Frost &amp; Sullivan notes that growth opportunities are increasingly concentrated around biologics and next-generation modalities, including GLP-1 therapies, antibody-drug conjugates (ADCs), radioligand therapies, and cell and gene therapies, while surrounding ecosystems such as obesity care operating systems, specialised manufacturing capabilities, and confirmatory-ready clinical trial models offer significant whitespace opportunities.<\/p>\n<p>The study also forecasts a divergence in growth trajectories between traditional small molecules and large molecules. While small molecules will remain the industry&#8217;s cash-flow backbone, biologics are expected to continue expanding their share of the market as companies invest in advanced therapeutic platforms and industrial-scale execution capabilities.<\/p>\n<p>&#8220;Pharma companies can no longer treat these pressures as a series of incremental challenges,&#8221; Gupta concludes. &#8220;The organisations that thrive will be those willing to rebuild their operating models around resilience, speed, disciplined innovation, and scalable execution.&#8221;<\/p>\n<p>To claim your complimentary extract from this Growth Opportunity Analysis, click here: <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4708731-1&amp;h=1154136858&amp;u=https%3A%2F%2Fshorturl.at%2FQABlD&amp;a=https%3A%2F%2Fshorturl.at%2FQABlD\" target=\"_blank\" rel=\"nofollow\" style=\"color: #0000FF\">https:\/\/shorturl.at\/QABlD<\/a><\/p>\n<p>To purchase the full report, please visit our store:\u00a0<a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4708731-1&amp;h=1528978185&amp;u=https%3A%2F%2Fstore.frost.com%2Fgrowth-opportunities-in-global-pharmaceutical-industry-2026.html&amp;a=Pharmaceutical+Industry+Growth+2026+%7C+Frost+%26+Sullivan\" target=\"_blank\" rel=\"nofollow\" style=\"color: #0000FF\">Pharmaceutical Industry Growth 2026 | Frost &amp; Sullivan<\/a><\/p>\n<p><b>About Frost &amp; Sullivan<\/b><\/p>\n<p>Frost &amp; Sullivan, the Transformational Growth Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation, and leadership. The company&#8217;s Growth Pipeline as a Service provides the CEO&#8217;s Growth Team with transformational strategies and best-practice models to drive the generation, evaluation, and implementation of powerful growth opportunities. For over 60 years, Frost &amp; Sullivan has partnered with investors, corporate leaders, and governments to identify, prioritise, and execute transformational growth strategies.<\/p>\n<p>Your Transformational Growth Journey Starts Here:\u00a0<a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4708731-1&amp;h=1663950539&amp;u=https%3A%2F%2Fgo.frost.com%2Fgpdialog%3Fcampaign_source%3Dglobal%26utm_medium%3DPR%26utm_source%3Dprnewswire&amp;a=Schedule+Your+Growth+Pipeline+Dialog%E2%84%A2\" target=\"_blank\" rel=\"nofollow\" style=\"color: #0000FF\"><b>Schedule Your Growth Pipeline Dialog&#x2122;<\/b><\/a>\u00a0with the Frost &amp; Sullivan team.<\/p>\n<p><b>Contact:<br \/><\/b><\/p>\n<p>Kristina Menzefricke<br \/>Marketing &amp; Communications<br \/>Global Customer Experience, Frost &amp; Sullivan<br \/><a href=\"mailto:kristina.menzefricke@frost.com\" target=\"_blank\" rel=\"nofollow\" style=\"color: #0000FF\">kristina.menzefricke@frost.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>New Frost &amp; Sullivan analysis reveals that future winners will be those that can execute faster, industrialise innovation, and navigate mounting pricing and geopolitical pressures LONDON, June 11, 2026 \/PRNewswire\/ &#8212; Frost &amp; Sullivan&#8217;s latest analysis, Growth Opportunities in Global Pharmaceutical Industry, 2026, finds that the pharmaceutical industry is entering a period of profound transformation [&#8230;]\n","protected":false},"author":1,"featured_media":85254,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-81661","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Frost &amp; Sullivan: Global Pharmaceutical Industry Faces a High-Stakes Reset as AI, Biologics, and Supply Resilience Redefine Growth Through 2031 - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/frost-sullivan-global-pharmaceutical-industry-faces-a-high-stakes-reset-as-ai-biologics-and-supply-resilience-redefine-growth-through-2031\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Frost &amp; Sullivan: Global Pharmaceutical Industry Faces a High-Stakes Reset as AI, Biologics, and Supply Resilience Redefine Growth Through 2031\" \/>\n<meta property=\"og:description\" content=\"New Frost &amp; Sullivan analysis reveals that future winners will be those that can execute faster, industrialise innovation, and navigate mounting p\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/frost-sullivan-global-pharmaceutical-industry-faces-a-high-stakes-reset-as-ai-biologics-and-supply-resilience-redefine-growth-through-2031\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-11T00:00:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/05\/SaigonBiz-Feature-Image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1074\" \/>\n\t<meta property=\"og:image:height\" content=\"716\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/frost-sullivan-global-pharmaceutical-industry-faces-a-high-stakes-reset-as-ai-biologics-and-supply-resilience-redefine-growth-through-2031\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/frost-sullivan-global-pharmaceutical-industry-faces-a-high-stakes-reset-as-ai-biologics-and-supply-resilience-redefine-growth-through-2031\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Frost &amp; Sullivan: Global Pharmaceutical Industry Faces a High-Stakes Reset as AI, Biologics, and Supply Resilience Redefine Growth Through 2031\",\"datePublished\":\"2026-06-11T00:00:24+00:00\",\"dateModified\":\"2026-06-11T00:00:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/frost-sullivan-global-pharmaceutical-industry-faces-a-high-stakes-reset-as-ai-biologics-and-supply-resilience-redefine-growth-through-2031\/\"},\"wordCount\":617,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/frost-sullivan-global-pharmaceutical-industry-faces-a-high-stakes-reset-as-ai-biologics-and-supply-resilience-redefine-growth-through-2031\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/frost-sullivan-global-pharmaceutical-industry-faces-a-high-stakes-reset-as-ai-biologics-and-supply-resilience-redefine-growth-through-2031\/\",\"name\":\"Frost &amp; Sullivan: Global Pharmaceutical Industry Faces a High-Stakes Reset as AI, Biologics, and Supply Resilience Redefine Growth Through 2031 - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2026-06-11T00:00:24+00:00\",\"dateModified\":\"2026-06-11T00:00:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/frost-sullivan-global-pharmaceutical-industry-faces-a-high-stakes-reset-as-ai-biologics-and-supply-resilience-redefine-growth-through-2031\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/frost-sullivan-global-pharmaceutical-industry-faces-a-high-stakes-reset-as-ai-biologics-and-supply-resilience-redefine-growth-through-2031\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/frost-sullivan-global-pharmaceutical-industry-faces-a-high-stakes-reset-as-ai-biologics-and-supply-resilience-redefine-growth-through-2031\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Frost &amp; Sullivan: Global Pharmaceutical Industry Faces a High-Stakes Reset as AI, Biologics, and Supply Resilience Redefine Growth Through 2031\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Frost &amp; Sullivan: Global Pharmaceutical Industry Faces a High-Stakes Reset as AI, Biologics, and Supply Resilience Redefine Growth Through 2031 - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/frost-sullivan-global-pharmaceutical-industry-faces-a-high-stakes-reset-as-ai-biologics-and-supply-resilience-redefine-growth-through-2031\/","og_locale":"en_US","og_type":"article","og_title":"Frost &amp; Sullivan: Global Pharmaceutical Industry Faces a High-Stakes Reset as AI, Biologics, and Supply Resilience Redefine Growth Through 2031","og_description":"New Frost &amp; Sullivan analysis reveals that future winners will be those that can execute faster, industrialise innovation, and navigate mounting p","og_url":"https:\/\/english.saigonbiz.com\/vn\/frost-sullivan-global-pharmaceutical-industry-faces-a-high-stakes-reset-as-ai-biologics-and-supply-resilience-redefine-growth-through-2031\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2026-06-11T00:00:24+00:00","og_image":[{"width":1074,"height":716,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/05\/SaigonBiz-Feature-Image.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/frost-sullivan-global-pharmaceutical-industry-faces-a-high-stakes-reset-as-ai-biologics-and-supply-resilience-redefine-growth-through-2031\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/frost-sullivan-global-pharmaceutical-industry-faces-a-high-stakes-reset-as-ai-biologics-and-supply-resilience-redefine-growth-through-2031\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Frost &amp; Sullivan: Global Pharmaceutical Industry Faces a High-Stakes Reset as AI, Biologics, and Supply Resilience Redefine Growth Through 2031","datePublished":"2026-06-11T00:00:24+00:00","dateModified":"2026-06-11T00:00:24+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/frost-sullivan-global-pharmaceutical-industry-faces-a-high-stakes-reset-as-ai-biologics-and-supply-resilience-redefine-growth-through-2031\/"},"wordCount":617,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/frost-sullivan-global-pharmaceutical-industry-faces-a-high-stakes-reset-as-ai-biologics-and-supply-resilience-redefine-growth-through-2031\/","url":"https:\/\/english.saigonbiz.com\/vn\/frost-sullivan-global-pharmaceutical-industry-faces-a-high-stakes-reset-as-ai-biologics-and-supply-resilience-redefine-growth-through-2031\/","name":"Frost &amp; Sullivan: Global Pharmaceutical Industry Faces a High-Stakes Reset as AI, Biologics, and Supply Resilience Redefine Growth Through 2031 - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2026-06-11T00:00:24+00:00","dateModified":"2026-06-11T00:00:24+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/frost-sullivan-global-pharmaceutical-industry-faces-a-high-stakes-reset-as-ai-biologics-and-supply-resilience-redefine-growth-through-2031\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/frost-sullivan-global-pharmaceutical-industry-faces-a-high-stakes-reset-as-ai-biologics-and-supply-resilience-redefine-growth-through-2031\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/frost-sullivan-global-pharmaceutical-industry-faces-a-high-stakes-reset-as-ai-biologics-and-supply-resilience-redefine-growth-through-2031\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Frost &amp; Sullivan: Global Pharmaceutical Industry Faces a High-Stakes Reset as AI, Biologics, and Supply Resilience Redefine Growth Through 2031"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/81661","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=81661"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/81661\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/85254"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=81661"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=81661"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=81661"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}